MREO
Mereo Biopharma Group
$0.30
+$0.01 (+4.86%)Jul 27, 2026
Key metrics
The numbers that frame MREO today
- Market cap
- $48.20M
- P/E (TTM)
- -1.3
- EV / FCF
- -0.4
- Gross margin
- 73.6%
- EV / Sales
- 24.0
- ROIC
- 3,614.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.20
- 52wk High
- $2.37
Growth
Revenue and earnings trend for MREO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MREO
Is Mereo Biopharma Group a good buy?
No. Mereo Biopharma Group has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Mereo Biopharma Group is selling at a very high price.
What is the market capitalization of MREO?
Mereo Biopharma Group's market capitalization is $48.20M.
What is the P/E ratio for MREO stock?
Mereo Biopharma Group's current P/E ratio is -1.3.
What is the 52-week high for MREO stock?
The 52-week high for Mereo Biopharma Group is $2.37. The current close of $0.30 is 87.3% below that high.
What is the 52-week low for MREO stock?
The 52-week low for Mereo Biopharma Group is $0.20. The current close of $0.30 is 51% above that low.
Does MREO stock pay dividends?
Mereo Biopharma Group does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MREO?
Mereo Biopharma Group's Debt / Equity ratio is 0.